-
December 01, 2016
PURE Bioscience Inc. announced the closing of their PIPE offering in the amount of $1,900,000. EG&S acted as counsel to the Placement Agent.
-
November 30, 2016
Amanda M. Fugazy, a member of the Firm, presented at the HUB Food Service Industry Workshop and prepared the Restaurant Management Employment Law Overview. Click here to read it.
-
November 30, 2016
Glen Sproviero, an Associate of the Firm, was invitied by Lawline to present a CLE entitled “Federal Criminal Procedure: The Basics”. The course examined the various stages of a federal criminal prosecution, including the requirements for probable cause, appearances before a magistrate, arraignment, pretrial motions, trial, and sentencing. It also discussed major policy issues such as crime control and due process models of criminal justice, along with ethical considerations and political concerns.
Click here to view the presentation.
-
November 29, 2016
Bellerophon Therapeutics Inc. announced the closing of their Registered Direct offering in the amount of $12,000.000. EG&S acted as counsel to the Placement Agent.
-
November 29, 2016
Cellectar Biosciences, Inc. announced the closing of their Underwritten offering in the amount of $9,200,000. EG&S acted as counsel to the Underwriter.
-
November 29, 2016
Rosetta Genomics Ltd. announced the closing of their PIPE offering in the amount of $3,707,500. EG&S acted as counsel to the Investor.
-
November 23, 2016
MotifBio PLC announced the closing of their Underwritten offering in the amount of $17,020,667. EG&S acted as counsel to the Underwriter.
-
November 23, 2016
Client Alert: Federal Judge Blocks Implementation
As we previously advised, on May 18, 2016, the U.S. Department of Labor published the final rule updating the overtime regulations. Click here to read the full alert.
-
November 21, 2016
MagneGas Corporation announced the closing of their Shelf offering in the amount of $3,000,000. EG&S acted as counsel to the Investor.
-
November 09, 2016
Bridgeline Digital Inc. announced the closing of their PIPE offering in the amount of $1,091,901. EG&S acted as counsel to the Placement Agent.
-
November 03, 2016
Sunshine Heart, Inc. announced the closing of their Registered Direct offering in the amount of $3,600,000. EG&S acted as counsel to the Placement Agent.
-
November 02, 2016
POET Technologies, Inc. announced the closing of their Registered Direct offering in the amount of CDN$12,528,000. EG&S acted as counsel to the Placement Agent.
-
October 28, 2016
Richard P. Kaye, a member of the Firm, participated as a panelist in the session entitled Building a Better Arbitration: Avoiding Pitfalls and Problems at a CLE program sponsored by the Dispute Resolution Section of the New York State Bar Association held at New York Law School.
-
October 21, 2016
ImmuCell Corporation announced the closing of their PIPE offering in the amount of $3,464,370. EG&S acted as counsel to the Placement Agent.
-
October 17, 2016
ToughBuilt Industries, Inc. announced the closing of their PIPE offering in the amount of $5,700,000. EG&S acted as counsel to the Investor.
-
October 17, 2016
PFO Global, Inc. announced the closing of their PIPE offering in the amount of $431,200. EG&S acted as counsel to the Investor.
-
October 12, 2016
Inventergy, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Company.
-
September 29, 2016
Histogenics Corporation announced the closing of their PIPE offering in the amount of $30,000,000. EG&S acted as counsel to the Placement Agent.
-
September 29, 2016
BioPharma X Corporation announced the closing of their Registered Direct offering in the amount of $930,000. EG&S acted as counsel to the Placement Agent.
-
September 28, 2016
Apricus BioSciences Inc. announced the closing of their Registered Direct offering in the amount of $3,734,286. EG&S acted as counsel to the Placement Agent.
-
September 21, 2016
OurCrowd announced the closing of their Series C Offering in the amount of $71,000,000. EG&S acted as counsel to OurCrowd.
-
September 19, 2016
Rexahn Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Placement Agent.
-
September 15, 2016
CytoDyn, Inc. announced the closing of their Registered Direct offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.
-
September 14, 2016
Cancer Genetics, Inc. announced the closing of their Registered Direct offering in the amount of $5,500,000. EG&S acted as counsel to the Placement Agent.
-
September 14, 2016
Real Goods Solar, Inc. announced the closing of their Underwritten offering in the amount of $2,407,125. EG&S acted as counsel to the Underwriter.